Group A | Group B | Group C | p value | |
---|---|---|---|---|
Number of patients (n) | 20 | 15 | 21 | / |
Number of knees (n) | 29 | 26 | 36 | / |
Number of operated knees (unilateral/bilateral) (n) | 11/9 | 4/11 | 6/15 | / |
Age (years) | 53.91 ± 11.02 | 53.51 ± 11.11 | 48.21 ± 11.94 | 0.88 |
BMI (kg/m2) | 23.42 ± 2.86 | 22.52 ± 3.84 | 22.12 ± 4.24 | 0.40 |
Sex (female/male) (n) | 14/6 | 13/2 | 18/3 | 0.35 |
DAS28 | 2.56 ± 0.63 | 2.68 ± 0.43 | 2.36 ± 0.63 | 0.09 |
Flexion deformity (%) | 15 (51.72) | 18 (69.23) | 22 (61.11) | 0.41 |
General anesthesia/non general anesthesia(n) | 12/8 | 12/3 | 13/8 | 0.31 |
Duration of medication treatment after surgery(years) | N/A | 8.13 ± 2.42 | 8.33 ± 2.63 | 0.80 |
Pre-op HSS | 43.61 ± 16.32 | 42.02 ± 14.32 | 42.01 ± 17.73 | 0.91 |
Pre-op ROM (°) | 78.51 ± 34.79 | 78.73 ± 30.82 | 89.81 ± 28.22 | 0.25 |
Pre-op pain | 4.96 ± 0.96 | 4.65 ± 1.02 | 3.48 ± 0.87 | 0.06 |
Pre-op function | 18.28 ± 7.11 | 18.85 ± 7.79 | 18.00 ± 9.09 | 0.92 |
Pre-op VAS | 5.93 ± 0.59 | 6.37 ± 0.63 | 6.76 ± 0.53 | 0.12 |
Pre-op WBC (*109/L) | 6.75 ± 1.81 | 7 ± 1.92 | 7.05 ± 2.58 | 0.88 |
Pre-op HGB (g/L) | 119.12 ± 17.09 | 111.21 ± 14.22 | 116.22 ± 18.21 | 0.34 |
Pre-op CRP (mg/L) # | 4.5 (1.6–15.3) | 15.0 (4.0–27.9) | 8.5 (1.7–25.9) | 0.18 |
Pre-op ESR (mm/h) # | 27.0 (12.0–64.0) | 58.0 (38.5–78.0) | 32.0 (14.5–65.3) | 0.06 |
Pre-op RF (U/ml) # | 39.0 (10.4–106.0) | 64.0 (28.0–189.5) | 31.2 (10.7–131.3) | 0.32 |